AU2446495A - Naphthalene derivatives, method of preparation and use - Google Patents

Naphthalene derivatives, method of preparation and use

Info

Publication number
AU2446495A
AU2446495A AU24464/95A AU2446495A AU2446495A AU 2446495 A AU2446495 A AU 2446495A AU 24464/95 A AU24464/95 A AU 24464/95A AU 2446495 A AU2446495 A AU 2446495A AU 2446495 A AU2446495 A AU 2446495A
Authority
AU
Australia
Prior art keywords
preparation
naphthalene derivatives
naphthalene
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24464/95A
Inventor
Mark Ladlow
Peter Charles North
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2446495A publication Critical patent/AU2446495A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU24464/95A 1994-04-21 1995-04-19 Naphthalene derivatives, method of preparation and use Abandoned AU2446495A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9407919A GB9407919D0 (en) 1994-04-21 1994-04-21 Chemical compounds
PCT/EP1995/001415 WO1995029173A1 (en) 1994-04-21 1995-04-19 Naphthalene derivatives, method of preparation and use

Publications (1)

Publication Number Publication Date
AU2446495A true AU2446495A (en) 1995-11-16

Family

ID=10753893

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24464/95A Abandoned AU2446495A (en) 1994-04-21 1995-04-19 Naphthalene derivatives, method of preparation and use

Country Status (8)

Country Link
EP (1) EP0821681A1 (en)
JP (1) JPH10502336A (en)
AU (1) AU2446495A (en)
CO (1) CO4370018A1 (en)
GB (1) GB9407919D0 (en)
IL (1) IL113431A0 (en)
WO (1) WO1995029173A1 (en)
ZA (1) ZA953140B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998461A (en) * 1994-10-21 1999-12-07 Adir Et Compagnie Tricyclic amide compounds
FR2725985B1 (en) * 1994-10-21 1996-11-15 Adir NOVEL TRICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US6071946A (en) * 1994-10-21 2000-06-06 Adir Et Compagnie Tricyclic urea compounds
FR2732964B1 (en) * 1995-04-14 1997-05-16 Adir NOVEL TRICYCLIC AMIDES, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0748627A3 (en) * 1995-06-14 1997-05-21 Lilly Co Eli Melatonin agonists for use in the treatment of benign prostatic hyperplasia
DE69713294T3 (en) * 1996-03-08 2009-01-15 Takeda Pharmaceutical Co. Ltd. Tricyclic compounds with binding affinity for melatonin receptors, their production and use
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
AUPO274596A0 (en) * 1996-10-04 1996-10-31 Armstrong, Stuart Maxwell Method for the treatment of neurological or neuropsychiatric disorders
US6310085B1 (en) 1997-10-03 2001-10-30 Clarencew Pty Ltd. Method for the treatment of neurological or neuropsychiatric disorders
TW476758B (en) * 1996-12-10 2002-02-21 Bristol Myers Squibb Co Benzodioxole, benzofuran, dihydrobenzofuran and benzodioxane melatonergic agents
WO1998038991A1 (en) * 1997-03-05 1998-09-11 Bristol-Myers Squibb Company Polycyclic ethyl alkylamide melatonergic agents
FR2763335B1 (en) * 1997-05-16 2000-11-24 Adir NOVEL SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2773798B1 (en) * 1998-01-16 2001-02-02 Adir NOVEL TRICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP1082115A4 (en) * 1998-06-05 2002-10-24 Bristol Myers Squibb Co Heterocyclic cis cyclopropane derivatives as melatonergic agents
EP1189900B1 (en) 1999-06-30 2004-01-14 Bristol-Myers Squibb Company Heterocyclic aminopyrrolidine derivatives as melatonergic agents
DE60019619T2 (en) 1999-08-20 2006-03-02 Takeda Chemical Industries, Ltd. DIHYDROBENZOFURANDERIVATE, PROCESS FOR THEIR MANUFACTURE AND MEDIUM
US7468178B2 (en) 1999-11-24 2008-12-23 Neurosciences Research Foundation, Inc. Methods for identifying compounds that modulate vigilance states
US6730287B1 (en) * 2000-04-03 2004-05-04 Neurosciences Research Foundation Inc. Methods for identifying compounds that modulate vigilance states
CN109251151A (en) * 2017-07-12 2019-01-22 北京广为医药科技有限公司 N- (2- (substitution-naphthalene -1- base) ethyl) substituted amide class compound, its preparation and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1590648A (en) * 1976-12-01 1981-06-03 Ciba Geigy Ag N-((naphthothienyl or n-phenanthryl)alkyl) imidazoles their preparation and compositions containing them
EP0510068B1 (en) * 1990-01-11 1999-04-14 PHARMACIA & UPJOHN COMPANY NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS

Also Published As

Publication number Publication date
EP0821681A1 (en) 1998-02-04
JPH10502336A (en) 1998-03-03
CO4370018A1 (en) 1996-10-07
WO1995029173A1 (en) 1995-11-02
GB9407919D0 (en) 1994-06-15
IL113431A0 (en) 1995-07-31
ZA953140B (en) 1996-01-05

Similar Documents

Publication Publication Date Title
AU1574895A (en) Tetracyclic derivatives, process of preparation and use
AU1108695A (en) Aza-4-iminoquinolines, methods of preparing them and their use
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU4978097A (en) Catalyst and method of preparation
AU2446495A (en) Naphthalene derivatives, method of preparation and use
AU6124296A (en) Novel dolastatin derivatives, their preparation and use
AU6514196A (en) Heterocyclic compounds, their preparation and use
AU4777097A (en) Novel piperidineketocarboxylic acid derivatives, their preparation and use
AU3839895A (en) Heterocyclic compounds, their preparation and use
AP9400706A0 (en) Indole derivatives, method of preparation and use
AU1874295A (en) Sphingoid bases and methods for their preparation and use
AU6514296A (en) Heterocyclic compounds, their preparation and use
AU7095296A (en) Phosphorylamides, their preparation and use
AU2454195A (en) Synthetic method of hymenialdisine and its derivatives and their synthetic intermediates, and those synthetic intermediates
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU4509696A (en) 3-benzoylpyridine derivatives, their preparation and their use as herbicides
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
AU2649997A (en) Transfer and method for its preparation and use
AU8578598A (en) Anti-inflammatory factor, method of isolation, and use
AU3650695A (en) New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
AU7135996A (en) Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use
AU2601495A (en) Sequence-specific endonucleases, and preparation and use of same
AU2930995A (en) Silylmethyl-aniline derivatives, methods of preparation and use thereof as drugs